Vistabel 4 Allergan jedinice/0,1 ml, prašak za otopinu za injekciju
| Name | Vistabel 4 Allergan jedinice/0,1 ml, prašak za otopinu za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-430530691 |
| Active Substance | neurotoksin Clostridium botulinum tip A (900 kDa) |
| Composition | 1 bočica s praškom za otopinu za injekciju sadrži 50 ili 100 Allergan jedinica neurotoksina tipa A (iz bakterije Clostridium botulinum) nakon rekonstitucije otopina za injekciju sadržava 4 Allergan jedinice u 0,1 mL |
| Pharmaceutical Form | prašak za otopinu za injekciju |
| Manufacturer | Allergan Pharmaceuticals Ireland, Westport, County Mayo, Irska AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Njemačka |
| Marketing Authorisation Holder | AbbVie d.o.o., Strojarska cesta 20, Zagreb, Hrvatska |
| Marketing Authorisation Date | 02.11.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/62 |
| Registration Number | 381-12-01/70-22-68 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | M03AX01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
